| Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease PTR Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA ... New England Journal of Medicine 376 (18), 1713-1722, 2017 | 5557 | 2017 |
| 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the … SV Konstantinides, G Meyer, C Becattini, H Bueno, GJ Geersing, ... European heart journal 41 (4), 543-603, 2020 | 4365 | 2020 |
| Efficacy and safety of low-dose colchicine after myocardial infarction JC Tardif, S Kouz, DD Waters, OF Bertrand, R Diaz, AP Maggioni, FJ Pinto, ... New England journal of medicine 381 (26), 2497-2505, 2019 | 2085 | 2019 |
| Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients SCO Investigators. New England Journal of Medicine 376 (16), 1527-1539, 2017 | 1755* | 2017 |
| Effect of cyclosporine on reperfusion injury in acute myocardial infarction C Piot, P Croisille, P Staat, H Thibault, G Rioufol, N Mewton, R Elbelghiti, ... New England Journal of Medicine 359 (5), 473-481, 2008 | 1628 | 2008 |
| Cyclosporine before PCI in patients with acute myocardial infarction TT Cung, O Morel, G Cayla, G Rioufol, D Garcia-Dorado, D Angoulvant, ... New England Journal of Medicine 373 (11), 1021-1031, 2015 | 736 | 2015 |
| Prehospital ticagrelor in ST-segment elevation myocardial infarction A Investigators New England Journal of Medicine 371 (11), 1016-27, 2014 | 730 | 2014 |
| Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines S Fazel, M Cimini, L Chen, S Li, D Angoulvant, P Fedak, S Verma, ... The Journal of clinical investigation 116 (7), 1865-1877, 2006 | 638 | 2006 |
| Long-term benefit of postconditioning H Thibault, C Piot, P Staat, L Bontemps, C Sportouch, G Rioufol, TT Cung, ... Circulation 117 (8), 1037-1044, 2008 | 562 | 2008 |
| The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2 MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, ... Journal of the American College of Cardiology 69 (7), 777-785, 2017 | 338 | 2017 |
| Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction N Mewton, P Croisille, G Gahide, G Rioufol, E Bonnefoy, I Sanchez, ... Journal of the American College of Cardiology 55 (12), 1200-1205, 2010 | 262 | 2010 |
| Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model BO Kim, H Tian, K Prasongsukarn, J Wu, D Angoulvant, S Wnendt, ... Circulation 112 (9_supplement), I-96-I-104, 2005 | 225 | 2005 |
| Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study J Mesnier, Y Cottin, P Coste, E Ferrari, F Schiele, G Lemesle, C Thuaire, ... The Lancet Public Health 5 (10), e536-e542, 2020 | 218 | 2020 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 200 | 2019 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 176 | 2021 |
| Causes of death and influencing factors in patients with atrial fibrillation L Fauchier, O Villejoubert, N Clementy, A Bernard, B Pierre, D Angoulvant, ... The American journal of medicine 129 (12), 1278-1287, 2016 | 171 | 2016 |
| Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens D Angoulvant, A Clerc, S Benchalal, C Galambrun, A Farre, Y Bertrand, ... Biorheology 41 (3‐4), 469-476, 2004 | 164 | 2004 |
| Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury D Angoulvant, F Ivanes, R Ferrera, PG Matthews, S Nataf, M Ovize The Journal of Heart and Lung Transplantation 30 (1), 95-102, 2011 | 160 | 2011 |
| How to define valvular atrial fibrillation? L Fauchier, R Philippart, N Clementy, T Bourguignon, D Angoulvant, ... Archives of cardiovascular diseases 108 (10), 530-539, 2015 | 153 | 2015 |
| The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction F Prunier, D Angoulvant, C Saint Etienne, E Vermes, M Gilard, C Piot, ... Basic research in cardiology 109, 1-10, 2014 | 148 | 2014 |
